Preparations of Rectal Suppositories Containing Artesunate.

Suzanne Persaud, Sandra Eid, Natalia Swiderski, Ioannis Serris, Hyunah Cho
Author Information
  1. Suzanne Persaud: School of Pharmacy and Health Sciences, Fairleigh Dickinson University, Florham Park, NJ 07932, USA.
  2. Sandra Eid: School of Pharmacy and Health Sciences, Fairleigh Dickinson University, Florham Park, NJ 07932, USA.
  3. Natalia Swiderski: School of Pharmacy and Health Sciences, Fairleigh Dickinson University, Florham Park, NJ 07932, USA.
  4. Ioannis Serris: School of Pharmacy and Health Sciences, Fairleigh Dickinson University, Florham Park, NJ 07932, USA.
  5. Hyunah Cho: School of Pharmacy and Health Sciences, Fairleigh Dickinson University, Florham Park, NJ 07932, USA.

Abstract

Rectal Artesunate suppositories are a useful option for pre-referral treatment of severe malaria, specifically in children under 6 years of age in remote malaria-endemic areas. The main challenges are to improve the solubility of drugs in the rectal fluids and prevent the product from turning rancid or melting in a tropical climate. In this short proof-of-concept study, three types of rectal suppositories of Artesunate were prepared: (i) polyethylene glycol (PEG)-based suppositories carrying free Artesunate (non-modified Artesunate), (ii) PEG-based suppositories carrying Artesunate-loaded micelles and (iii) 3D-printed suppositories carrying a PEG/Artesunate mixture. Physical parameters of suppositories, release profiles of Artesunate (the fastest to the slowest: ii≥i>iii) and thermostability (the most stable to the least stable: iii>ii>i) of suppositories at increased temperature were assessed to determine the advantages and disadvantages of each formulation.

Keywords

References

  1. Int J Pharm. 2016 Nov 20;513(1-2):717-724 [PMID: 27686053]
  2. Int J Pharm. 2019 Feb 10;556:106-116 [PMID: 30513398]
  3. Materials (Basel). 2018 Feb 16;11(2): [PMID: 29462901]
  4. Molecules. 2017 Feb 20;22(2): [PMID: 28230749]
  5. Int J Pharm. 2019 Sep 10;568:118494 [PMID: 31276763]
  6. Mol Pharm. 2019 Feb 4;16(2):552-560 [PMID: 30608705]
  7. Am J Trop Med Hyg. 2007 Apr;76(4):634-40 [PMID: 17426162]
  8. Pharm Res. 2018 Jul 11;35(9):176 [PMID: 29998405]
  9. Pharm Res. 2019 Jan 25;36(3):42 [PMID: 30684014]
  10. Int J Pharm. 2019 Mar 10;558:128-142 [PMID: 30639218]
  11. Cochrane Database Syst Rev. 2014 May 29;(5):CD009964 [PMID: 24869943]
  12. Br J Anaesth. 1984 Jan;56(1):69-82 [PMID: 6140933]
  13. Lancet. 2009 Feb 14;373(9663):557-66 [PMID: 19059639]
  14. Biol Pharm Bull. 1995 Sep;18(9):1289-91 [PMID: 8845826]
  15. Antimicrob Agents Chemother. 2006 Mar;50(3):968-74 [PMID: 16495259]
  16. Int J Pharm. 2013 Jan 30;441(1-2):218-26 [PMID: 23220079]

Word Cloud

Created with Highcharts 10.0.0suppositoriesartesunatecarryingRectalrectalmicellesusefuloptionpre-referraltreatmentseveremalariaspecificallychildren6yearsageremotemalaria-endemicareasmainchallengesimprovesolubilitydrugsfluidspreventproductturningrancidmeltingtropicalclimateshortproof-of-conceptstudythreetypesprepared:polyethyleneglycolPEG-basedfreenon-modifiediiPEG-basedartesunate-loadediii3D-printedPEG/artesunatemixturePhysicalparametersreleaseprofilesfastestslowest:ii≥i>iiithermostabilitystableleaststable:iii>ii>iincreasedtemperatureassesseddetermineadvantagesdisadvantagesformulationPreparationsSuppositoriesContainingArtesunate3Dprintingsuppository

Similar Articles

Cited By